Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether investigational study drug, AG-013736, and gemcitabine are effective in the first-line treatment of advanced pancreatic cancer.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT07259317 · Adenocarcinoma, Carcinoma, Pancreatic Ductal
NCT06704724 · Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, and more
NCT06974734 · Carcinoma, Non Small Cell Lung, Carcinoma, Pancreatic Ductal, and more
NCT05461430 · Pleural Effusion, Malignant, Ascites, Malignant, and more
NCT02750657 · Carcinoma, Pancreatic Ductal
Pfizer Investigational Site
Antioch, California
Pfizer Investigational Site
Corona, California
Pfizer Investigational Site
Glendora, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions